Literature DB >> 15235133

The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity.

George N Tzanakakis1, Andrew N Margioris, Aristidis M Tsatsakis, Michael P Vezeridis.   

Abstract

BACKGROUND: Cathepsin B, a lysosomal cysteine protease, has a major role in the mechanisms of tumor metastasis. The aim of the present work was to examine the correlation between cathepsin B activity and the metastatic potential of human pancreatic cancer.
METHODS: The primary cell line COLO 357 and the derivative tumor cell lines FG, L3.1, L3.2, L3.3, L3.4, and L3.5, which are characterized by progressively increasing metastatic potential, were injected intrasplenically in the athymic mice. Cathepsin B activity, metastasis, and ultrastructural characteristics were assessed.
RESULTS: An increased number of liver tumor nodules was observed with each subsequent intrasplenic inoculation (p = 0.001), associated with lymph node, splenic, and pancreatic involvement. Cathepsin B activity progressively increased (p = 0.001) and was strongly positively correlated with the metastatic potential. However, no correlation was found between the metastatic potential and ultrastructural characteristics.
CONCLUSIONS: These findings further support the central role of cathepsin B in metastasis in a combined in vitro/in vivo model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15235133     DOI: 10.1385/IJGC:34:1:27

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  48 in total

Review 1.  Growth dominance of the metastatic cancer cell: cellular and molecular aspects.

Authors:  R S Kerbel
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

2.  Cathepsin B on invasion and metastasis of gastric carcinoma.

Authors:  Y Liu; S Xiao; Y Shi; L Wang; W Ren; B F Sloane
Journal:  Chin Med J (Engl)       Date:  1998-09       Impact factor: 2.628

3.  Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma.

Authors:  N Suzuki; H R Withers; M W Koehler
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

4.  Cathepsin B in the growth of colorectal cancer: suppressive effect of leupeptin on the growth of DMH-induced rat colon neoplasm.

Authors:  Y Satoh; T Higashi; K Nouso; T Shiota; N Kinugasa; K Yoshida; S Uematsu; H Nakatsukasa; Y Nishimura; T Tsuji
Journal:  Acta Med Okayama       Date:  1996-12       Impact factor: 0.892

5.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

6.  Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.

Authors:  M Budihna; P Strojan; L Smid; J Skrk; I Vrhovec; A Zupevc; Z Rudolf; M Zargi; M Krasovec; B Svetic; N Kopitar-Jerala; J Kos
Journal:  Biol Chem Hoppe Seyler       Date:  1996-06

7.  Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma.

Authors:  R T Morgan; L K Woods; G E Moore; L A Quinn; L McGavran; S G Gordon
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

8.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.

Authors:  T Furukawa; X Fu; T Kubota; M Watanabe; M Kitajima; R M Hoffman
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

9.  Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.

Authors:  E Campo; J Muñoz; R Miquel; A Palacín; A Cardesa; B F Sloane; M R Emmert-Buck
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.

Authors:  D Cantero; H Friess; J Deflorin; A Zimmermann; M A Bründler; E Riesle; M Korc; M W Büchler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  5 in total

1.  Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.

Authors:  Lisa Sevenich; Uta Schurigt; Kathrin Sachse; Mieczyslaw Gajda; Fee Werner; Sebastian Müller; Olga Vasiljeva; Anne Schwinde; Nicole Klemm; Jan Deussing; Christoph Peters; Thomas Reinheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

2.  Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.

Authors:  Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Biochemistry       Date:  2020-03-31       Impact factor: 3.162

3.  AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D.

Authors:  Laurent Dumartin; Hannah J Whiteman; Mark E Weeks; Deepak Hariharan; Branko Dmitrovic; Christine A Iacobuzio-Donahue; Teresa A Brentnall; Mary P Bronner; Roger M Feakins; John F Timms; Caroline Brennan; Nicholas R Lemoine; Tatjana Crnogorac-Jurcevic
Journal:  Cancer Res       Date:  2011-09-26       Impact factor: 12.701

4.  Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.

Authors:  Min-Hong Hsieh; Jen-Pi Tsai; Shun-Fa Yang; Hui-Ling Chiou; Chia-Liang Lin; Yi-Hsien Hsieh; Horng-Rong Chang
Journal:  Cells       Date:  2019-08-21       Impact factor: 6.600

5.  Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β.

Authors:  Jyoti B Kaushal; Rakesh Bhatia; Ranjana K Kanchan; Pratima Raut; Surya Mallapragada; Quan P Ly; Surinder K Batra; Satyanarayana Rachagani
Journal:  Cancers (Basel)       Date:  2021-06-22       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.